Absolutely I do. Apparently so does Investor and others that follow AD trials (including Anavex's previous trial) or have read the clinical trial website that procludes NO other AD medications in the current trial. That's why based on actual trial results given in the original link would suggest plenty of placebo patients will actually score better at 48 weeks so no one should be shocked based on your prediction of zero.
Market Data 
Markets 
AI
